Devarati Mitra, M.D., Ph.D.
Department of Radiation Oncology, Division of Radiation Oncology
About Dr. Devarati Mitra
Dr. Devarati Mitra received her MD and PhD at Harvard Medical School before completing her residency training at the Harvard Radiation Oncology Program, working at Dana Farber Cancer Institute and Massachusetts General Hospital Cancer Center. She is now an Assistant Professor in the Department of Radiation Oncology at the University of Texas MD Anderson Cancer Center.
In her appointment to the Melanoma & Sarcoma Radiation Oncology section she specializes in the treatment of patients with melanoma, non-melanoma skin malignancies and bone or soft tissue sarcoma. Her clinical focus is on providing personalized patient care that brings the optimal radiation therapy approach to each patient’s unique cancer experience.
Her research is focused on how to combine modern radiation approaches with novel systemic therapies, including immunotherapy and molecularly targeted agents. She has received research funding from multiple extramural sources including the National Institutes of Health (NIH), American Society for Radiation Oncology (ASTRO) and American Society for Clinical Oncology (ASCO). Her research has been published across a variety of peer-reviewed journals and she is working on several clinical trials to continue to improve outcomes for cancer patients.
Present Title & Affiliation
Primary Appointment
Voluntary Clinical Assistant Professor, Division of Radiation Oncology, The University of Houston College of Medicine, Houston, TX
Assistant Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Voluntary Clinical Assistant Professor, The University of Houston College of Medicine, Houston, TX
Assistant Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2014 | Harvard Medical School, Boston, Massachusetts, US, MD |
| 2012 | Harvard University, Boston, Massachusetts, US, Ph.D. in Biology & Biomedical Sciences |
| 2006 | Stanford University, Stanford, California, US, BS in Biological Sciences |
Postgraduate Training
| 2015-2019 | Clinical Residency, Radiation Oncology, Harvard Radiation Oncology Program, Boston, Massachusetts |
| 2014-2015 | Clinical Internship, Internal Medicine, Brigham & Women's Hospital, Boston, Massachusetts |
Board Certifications
| 2021 | American Board of Radiology |
Experience & Service
Administrative Appointments/Responsibilities
Mel/ Sarc Section Research Director, Department of Radiation Oncology Clinical Research Council, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present
Associate Director of Medical Student Education, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present
Other Appointments/Responsibilities
Associate Faculty Member, The University of Texas MD Anderson Cancer Center UT Health Houston Graduate School of Biomedical Sciences, Houston, TX, 2023 - Present
Member, Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX, 2023 - Present
Residency Education Case Conference Coordinator, Harvard Radiation Oncology Program, Cambridge, MA, 2018 - 2019
Medical Student Education Coordinator, Harvard Radiation Oncology Program, Cambridge, MA, 2018 - 2019
Non-Resident Tutor, Harvard University, Cambridge, MA, 2014 - 2018
Teaching Assistant, Patient- Doctor 2, Harvard Medical School, Cambridge, MA, 2013 - 2014
Teaching Assistant, Translational Pharmacology, Harvard Medical School, Cambridge, MA, 2011 - 2011
Doctoral Student Teaching Assistant, Molecular Basis of Disease, Harvard Medical School, Cambridge, MA, 2009 - 2011
Doctoral Student Teaching Assistant, Molecular Cell Biology, Harvard Medical School, Cambridge, MA, 2009 - 2011
Undergraduate Alumni Interviewer, Stanford University, Stanford, CA, 2008 - Present
Resident Tutor, Harvard University, Cambridge, MA, 2008 - 2014
Institutional Committee Activities
Member, Delphi Panel, 2025 - Present
Disease Site Leader, Clinical Trials Prioritization Review (CTPR), 2024 - Present
Member, NRG FLASH Group, 2024 - Present
Member, Melanoma Medical Oncology Faculty Search Committee, 2024 - 2025
Member, NCCN Melanoma: Cutaneous Guidelines Committee, 2024 - Present
Melanoma Panel Member, Melanoma Multidisciplinary Network Conference, 2023 - Present
Member, Scientific Review Committee, 2023 - Present
Member, MRF Mucosal Melanoma Translational Working Group, 2023 - Present
Radiation Oncology Lead, Cutaneous Melanoma Algorithm Review Committee, 2023 - Present
Member, MCC International Planning Committee, 2023 - 2024
Member, Advanced Radiation Oncology Fellowship Interview Committee, 2022 - Present
Member, The Art and Science of Managing the New Melanoma Landscape Planning Committee, 2022 - 2022
Chair, Faculty & Non-Faculty Seed Award Scientific Review Committee, 2021 - 2021
Member, Joint Madrid MD Anderson Committee, 2021 - 2022
Co-chair, Non-melanoma Skin Cancer MD Anderson CME Conference, 2021 - 2021
Member, Melanoma CME Conference Planning Committee, 2021 - 2021
Member, Sarcoma Multidisciplinary Planning Conference, 2021 - 2023
Member, MD Anderson Research Foundations Pilot Testing, 2021 - 2021
Chair, ROSI Boot Walk Faculty and Non-faculty Seed Awards Committee, 2021
Committee Member, ROSI Non Faculty Seed Award Scientific Review Committee, 2020
Melanoma/Sarcoma Section Liaison, RayStation Electron Planning Transition Team, 2020 - 2021
Melanoma/Sarcoma Representative, Radiation Oncology Clinical Research Committee, 2020 - Present
Team Member, Radiation Oncology Covid Recovery Workstream – Virtual Care, 2020 - 2020
Honors & Awards
| 2024 | Andrew Sabin Family Fellow, The University of Texas MD Anderson Cancer Center |
| 2023 | RSNA Scholar Award, Radiological Society of North America |
| 2023 | Gilbert Fletcher Rising Stars Award, The University of Texas MD Anderson Cancer Center |
| 2018 | Conquer Cancer Foundation Merit Award, American Society of Clinical Oncology |
| 2018 - 2019 | ASCO Young Investigator Award, American Society of Clinical Oncology |
| 2018 | Conquer Cancer Foundation Merit Award, Clinical Immuno-Oncology Symposium |
| 2018 | William Shipley Research Award, Massachusetts General Hospital |
| 2017 - 2018 | ASTRO Resident Seed Grant, American Society of Radiation Oncology |
| 2012 - 2014 | F30 Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship, National Institute of Environmental Health Sciences |
| 2011 | AACR Conference on Frontiers in Basic Cancer Research, American Association for Cancer Research |
| 2006 | Phi Beta Kappa National Honor Society, Phi Beta Kappa National Honor Society |
| 2006 | Goldwater Scholarship, Barry Goldwater Scholarship and Excellence in Education Program |
| 2006 | Graduated Summa Cum Laude in Biological Sciences, Stanford University |
| 2005 | Goldwater Scholarship, Barry Goldwater Scholarship and Excellence in Education Program |
| 2002 | Maryland Distinguished Scholar, Maryland |
| 2002 | United States Marine Corps Scholastic Excellence Award, United States Marine Corps |
| 2002 | National AP Scholar, The College Board |
| 2002 | National Merit Scholarship, National Merit Scholarship Corporation |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Liu K, Waldrop T, Aguilar E, Mims N, Neill D, Delahoussaye A, Li Z, Swanson D, Lin SH, Koong AC, Taniguchi CM, Loo BW Jr, Mitra D, Schuler E. Redefining FLASH Radiation Therapy: The Impact of Mean Dose Rate and Dose Per Pulse in the Gastrointestinal Tract. Int J Radiat Oncol Biol Phys 121(4):1063-1076, 2025. e-Pub 2025. PMID: 39424078.
- Salem AF, Chen MM, Williams MD, Swanson DM, McQuade JL, Amaria RN, Hanna EY, Bishop AJ, Farooqi AS, Guadagnolo BA, Su SY, Mitra D. Resectable Sinonasal Mucosal Melanoma in the Immunotherapy Era: Upfront Surgery vs. Neoadjuvant Therapy. Head Neck, 2025. e-Pub 2025. PMID: 39906003.
- Liu K, Titt U, Esplen N, Connell L, Konradsson E, Yang M, Wang X, Takaoka T, Li Z, Koong AC, Mitra D, Mohan R, Loo BW, Lin SH, Schuler E. Discordance in Acute Gastrointestinal Toxicity between Synchrotron-Based Proton and Linac-based Electron Ultra-High Dose Rate Irradiation. Int J Radiat Oncol Biol Phys, 2025. e-Pub 2025. PMID: 39862897.
- Bishop AJ, Mitra D, Farooqi A, Swanson DM, Hempel C, Willis T, Pearlnath C, Wang WL, Ratan R, Somaiah N, Benjamin RS, Torres KE, Hunt KK, Scally CP, Keung EZ, Satcher RL, Bird JE, Lin PP, Moon BS, Lewis VO, Roland CL, Guadagnolo BA. Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT-STS): Updated local control, late toxicities, and patient-reported outcomes. Cancer 131(1):e35542, 2025. e-Pub 2025. PMID: 39192597.
- Keatts SA, Salem AF, Swanson DM, Farooqi AS, Bishop AJ, Amaria RN, McQuade JL, Glitza Oliva IC, Diab A, Weiser R, Fisher SB, Goepfert RP, Ross MI, Ashleigh Guadagnolo B, Mitra D. Durable local control with hypofractionated radiation therapy for unresectable or metastatic melanoma. Clin Transl Radiat Oncol 49:100856, 2024. e-Pub 2024. PMID: 39308633.
- Yoder AK, Farooqi A, Mitra D, Livingston JA, Araujo DM, Sturgis EM, Goepfert R, Bishop AJ, Guadagnolo BA. Outcomes for Patients With Head and Neck Sarcoma Treated Curatively With Radiation Therapy and Surgery. Pract Radiat Oncol 14(5):e373-e382, 2024. e-Pub 2024. PMID: 38851534.
- Nasr LF, Zoghbi M, Lazcano R, Nakazawa M, Bishop AJ, Farooqi A, Mitra D, Guadagnolo BA, Benjamin R, Patel S, Ravi V, Araujo DM, Livingston A, Zarzour MA, Conley AP, Ratan R, Somaiah N, Lazar AJ, Roland C, Keung EZ, Nassif Haddad EF. High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center Experience. Cancers (Basel) 16(9), 2024. e-Pub 2024. PMID: 38730715.
- Farooqi AS, Yoder AK, Lin HY, Pasalic D, Erasmus J, Betancourt S, Wernz C, Mitra D, Zarzour MA, Somaiah N, Conley A, Ratan R, Livingston A, Araujo DM, Roland C, Scally C, Keung E, Gandhi SN, Ashleigh Guadagnolo B, Nguyen QN, Bishop AJ. SABR for Sarcoma Lung Metastases: Indications for Treatment and Guidance for Patient Selection. Int J Radiat Oncol Biol Phys 118(4):971-978, 2024. e-Pub 2024. PMID: 37914142.
- Cass S, Cope B, Bishop AJ, Chiang YJ, Ashleigh Guadagnolo B, Farooqi A, Morrison W, Witt RG, Seervai RNH, Garden AS, Fuller CD, Goepfert RP, Ross M, Gershenwald JE, Wong M, Aung PP, Keung EZ, Mitra D. Primary tumor site for localized Merkel cell carcinoma drives different management strategies without impacting oncologic outcomes. Radiother Oncol 188:109892, 2023. e-Pub 2023. PMID: 37659660.
- Chau BL, LaGuardia JS, Kim S, Zhang SC, Pletcher E, Sanford NN, Raldow AC, Singer L, Gong J, Padda SK, Kamrava M, Cohen T, Mitra D, Atkins KM. Association of Parental Status and Gender With Burden of Multidisciplinary Tumor Boards Among Oncology Physicians. JAMA Netw Open 6(10):e2340663, 2023. e-Pub 2023. PMID: 37906191.
- Yoder AK, Farooqi AS, Wernz C, Subramaniam A, Ravi V, Goepfert R, Sturgis EM, Mitra D, Bishop AJ, Guadagnolo BA. Outcomes after definitive treatment for cutaneous angiosarcomas of the face and scalp: Reevaluating the role of surgery and radiation therapy. Head Neck 45(8):1943-1951, 2023. e-Pub 2023. PMID: 37272774.
- Mitra D, Farr M, Nagarajan P, Ho J, Bishop AJ, Jhingran A, Farooqi AS, Frumovitz M, Amaria RN, McQuade JL, Jazaeri AA, Guadagnolo BA. Gynecologic tract melanoma in the contemporary therapeutic era: high rates of local and distant disease progression. Gynecol Oncol 167(3):483-489, 2022. e-Pub 2022. PMID: 36229264.
- Guadagnolo BA, Bassett RL, Mitra D, Farooqi A, Hempel C, Dorber C, Willis T, Wang WL, Ratan R, Somaiah N, Benjamin RS, Torres KE, Hunt KK, Scally CP, Keung EZ, Satcher RL, Bird JE, Lin PP, Moon BS, Lewis VO, Roland CL, Bishop AJ. Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial. Lancet Oncol 23(12):1547-1557, 2022. e-Pub 2022. PMID: 36343656.
- Bishop AJ, Amini B, Lin H, Raza SM, Patel S, Grosshans DR, Ghia A, Farooqi A, Guadagnolo BA, Mitra D, Akdemir KC, Lazar AJ, Wang WL, Alvarez-Breckenridge C, Bird J, Rhines LD, Somaiah N, Conley AP. Immune Checkpoint Inhibitors Have Clinical Activity in Patients With Recurrent Chordoma. J Immunother 45(8):374-378, 2022. e-Pub 2022. PMID: 35943386.
- Bishop AJ, Zheng J, Subramaniam A, Ghia AJ, Wang C, McGovern SL, Patel S, Guadagnolo BA, Mitra D, Farooqi A, Reardon MJ, Kim B, Guha-Thakurta N, Li J, Ravi V. Cardiac Angiosarcomas: Risk of Brain Metastasis and Hemorrhage Warrants Frequent Surveillance Imaging and Early Intervention. Am J Clin Oncol 45(6):258-263, 2022. e-Pub 2022. PMID: 35588225.
- Mitra D. Locoregional-Directed Therapy Is Still a Cornerstone of Anorectal Melanoma Management. Int J Radiat Oncol Biol Phys 112(5):1075, 2022. e-Pub 2022. PMID: 35286880.
- Ho J, Mattei J, Tetzlaff M, Williams MD, Davies MA, Diab A, Oliva ICG, McQuade J, Patel SP, Tawbi H, Wong MK, Fisher SB, Hanna E, Keung EZ, Ross M, Weiser R, Su SY, Frumovitz M, Meyer LA, Jazaeri A, Pettaway CA, Guadagnolo BA, Bishop AJ, Mitra D, Farooqi A, Bassett R, Faria S, Nagarajan P, Amaria RN. Neoadjuvant Checkpoint Inhibitor Immunotherapy for Resectable Mucosal Melanoma. Front Oncol 12:1001150, 2022. e-Pub 2022. PMID: 36324592.
- Mitra D, Rao PK, Nagarajan P, Bishop AJ, Farooqi AS, Gershenwald JE, Wargo J, Keung EZ, Fisher SB, Amaria RN, Davies MA, Ross MI, Guadagnolo BA. Outcomes After Sphincter-Sparing Local Therapy for Anorectal Melanoma: 1989 to 2020. Pract Radiat Oncol 12(5):437-445, 2022. e-Pub 2022. PMID: 35278716.
- Boyce-Fappiano D, Damron EP, Farooqi A, Mitra D, Conley AP, Somaiah N, Araujo DM, Livingston JA, Ratan R, Keung EZ, Roland CL, Guadagnolo BA, Bishop AJ. Hypofractionated radiation therapy for unresectable or metastatic sarcoma lesions. Adv Radiat Oncol 7(3):100913, 2022. e-Pub 2022. PMID: 35647398.
- Mitra D, Ologun G, Keung EZ, Goepfert RP, Amaria RN, Ross MI, Gershenwald JE, Lucci A, Fisher SB, Davies MA, Lee JE, Bishop AJ, Farooqi AS, Wargo J, Guadagnolo BA. Nodal Recurrence is a Primary Driver of Early Relapse for Patients with Sentinel Lymph Node-Positive Melanoma in the Modern Therapeutic Era. Ann Surg Oncol 28(7):3480-3489, 2021. e-Pub 2021. PMID: 33856603.
- Mitra D, Devlin PM, Buzurovic I, Thornton K, Lam AC, Raut CP, Baldini EH, Lam MB. Clinical outcomes following HDR surface applicator brachytherapy for angiosarcoma of the scalp and face. J Contemp Brachytherapy 2020:7615248, 2021. e-Pub 2021. PMID: 33897791.
- Mitra D, Devlin PM, Buzurovic I, Thornton K, Lam AC, Raut CP, Baldini EH, Lam MB. Clinical outcomes following high-dose-rate surface applicator brachytherapy for angiosarcoma of scalp and face. J Contemp Brachytherapy 13(2):172-178, 2021. e-Pub 2021. PMID: 33897791.
- Boyce-Fappiano D, Guadagnolo BA, Ratan R, Wang WL, Wagner MJ, Patel S, Livingston JA, Lin PP, Diao K, Mitra D, Farooqi A, Lazar AJ, Roland CL, Bishop AJ. Evaluating the Soft Tissue Sarcoma Paradigm for the Local Management of Extraskeletal Ewing Sarcoma. Oncologist 26(3):250-260, 2021. e-Pub 2021. PMID: 33289298.
- Lee G, Kim DW, Muralidhar V, Mitra D, Horick NK, Eyler CE, Hong TS, Drapek LC, Allen JN, Blaszkowsky LS, Giantonio B, Parikh AR, Ryan DP, Clark JW, Wo JY. Chemoradiation-related lymphopenia and its association with survival in patients with squamous cell carcinoma of the anal canal. Oncologist 25(12):1015-1022, 2020. e-Pub 2020. PMID: 32827337.
- Yerramilli D, Drapek L, Nipp RD, Horick N, Moran SMC, Noé B, D'Arpino SM, Mitra D, Hong TS, Ryan DP, Dizon DS, Wo J. Sexual Function, Quality of Life, and Mood After Radiation Therapy in Patients with Anal Cancer. J Gastrointest Cancer 51(1):204-210, 2020. e-Pub 2020. PMID: 30980294.
- Mitra D, Pei Y, Buzurovic I, Devlin PM, Thornton K, Raut CP, Baldini EH, Lam MB. Angiosarcoma of the Scalp and Face: A Dosimetric Comparison of HDR Surface Applicator Brachytherapy and VMAT. Sarcoma 2020:7615248, 2020. e-Pub 2020. PMID: 32908445.
- Mitra, D, Chen, YH, Li, R, Hermann, G, Atkins, KM, Kozono, D, Baldini, EH, Aizer, A, Chukwueke, U, Mak, RH. EGFR mutant locally advanced non-small cell lung cancer is at increased risk of brain metastasis. Clinical and Translational Radiation Oncology 18:32-38, 2019. e-Pub 2019. PMID: 31341973.
- Mitra D, Chen YH, Li R, Hermann G, Atkins K, Kozono D, Baldini EH, Aizer A, Chukwueke U, Mak RH. EGFR mutant locally advanced non-small cell lung cancer is at increased risk of brain metastasis. Clin Transl Radiat Oncol 18:32-38, 2019. e-Pub 2019.
- Mito JK, Mitra D, Barysauskas CM, Mariño-Enriquez A, Morgan EA, Fletcher CDM, Raut CP, Baldini EH, Doyle LA. A Comparison of Outcomes and Prognostic Features for Radiation-Associated Angiosarcoma of the Breast and Other Radiation-Associated Sarcomas. Int J Radiat Oncol Biol Phys 104(2):425-435, 2019. e-Pub 2019. PMID: 30703514.
- Mitra D, Horick N, Brackett DG, Mouw KW, Hornick JL, Ferrone S, Hong TS, Mamon H, Clark JW, Parikh AP, Allen JN, Ryan DP, Ting DT, Deshpande W, Wo JY. High IDO1 expression is associated with poor outcome in anal cancer patients treated with definitive chemoradiotherapy. Oncologist 24(6):e275-e283, 2019. e-Pub 2019. PMID: 30755500.
- Mitra D, Clark JW, Shih HA, Oh KS, Brastianos PK, Wo JY, Strickland MR, Curry WT, Parikh AR, Corcoran RB, Ryan DP, Iafrate AJ, Borger DR, Lennerz JK, Hong TS. Enrichment of Her2 amplification in brain metastases from primary gastrointestinal malignancies. Oncologist 24(2):193-201, 2019. e-Pub 2019. PMID: 30373904.
- Fitarelli-Kiehl M, Ashtaputre R, Yu F, Supplee J, Paweletz C, Mitra D, Schoenfeld JD, Sarh P, Makrigiorgos GM. DNA end-repair and denaturation enhances digital droplet PCR-based analysis of small input liquid biopsies. Clin Chem 64(12):1762-1771, 2018. e-Pub 2018. PMID: 30274976.
- Rose B, Mitra D, Hong TS, Jee KW, Niemierko A, Drapek LN, Blaszkowsky LS, Allen JN, Murphy JE, Clark JW, Ryan DP, Wo JY. Irradiation of anatomically defined pelvic subsites and acute hematologic toxicity in anal cancer patients undergoing chemoradiation. Pract Radiat Oncol 7(5):e291-e297, 2017. e-Pub 2017. PMID: 28462895.
- Mitra D, Hong TS, Horick N, Rose B, Drapek LN, Blaszkowsky LS, Allen JN, Kwak EL, Murphy JE, Clark JW, Ryan DP, Cusack JC, Bordeianou LG, Berger DL, Wo JY. Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529. Adv Radiat Oncol 2(2):110-117, 2017. e-Pub 2017. PMID: 28740921.
- Shen CH, Kim SH, Trousil S, Frederick DT, Piris A, Yuan P, Cai L, Gu L, Li M, Lee JH, Mitra D, Fisher DE, Sullivan RJ, Flaherty KT, Zheng B. Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma. Nat Med 22(9):1056-61, 2016. e-Pub 2016. PMID: 27500726.
- Mitra D, Catalano PJ, Cimbak N, Damato AL, Muto MG, Viswanathan AN. The risk of lymphedema after postoperative radiation therapy in endometrial cancer. J Gynecol Oncol 27(1):e4, 2016. e-Pub 2016. PMID: 26463430.
- Mitra D, Nout R, Catalano PJ, Creutzberg C, Cimbak N, Lee L, Viswanathan AN. Rectal bleeding after radiation therapy for endometrial cancer. Radiother Oncol 115(2):240-5, 2015. e-Pub 2015. PMID: 26003340.
- Cooper ZA, Juneja VR, Sage PT, Frederick DT, Piris A, Mitra D, Lo JA, Hodi FS, Freeman GJ, Bosenberg MW, McMahon M, Flaherty KT, Fisher DE, Sharpe AH, Wargo JA. Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockade. Cancer Immunol Res 2(7):643-54, 2014. e-Pub 2014. PMID: 24903021.
- Luo X, Mitra D, Sullivan RJ, Wittner BS, Kimura AM, Pan S, Hoang MP, Brannigan BW, Lawrence DP, Flaherty KT, Sequist LV, McMahon M, Bosenberg MW, Stott SL, Ting DT, Ramaswamy S, Toner M, Fisher DE, Maheswaran S, Haber DA. Isolation and molecular characterization of circulating melanoma cells. Cell Rep 7(3):645-53, 2014. e-Pub 2014. PMID: 24746818.
- Liu S, Wang J, Su Y, Guerrero C, Zeng Y, Mitra D, Brooks PJ, Fisher DE, Song H, Wang Y. Quantitative assessment of Tet-induced oxidation products of 5-methylcytosine in cellular and tissue DNA. Nucleic Acids Research 41(13):6421-9, 2013. e-Pub 2013. PMID: 23658232.
- Frederick DT, Piris A, Cogdill AP, Cooper ZA, Lezcano C, Ferrone CR, Mitra D, Boni A, Newton LP, Liu C, Peng W, Sullivan RJ, Lawrence DP, Hodi FS, Overwijk WW, Lizée G, Murphy GF, Hwu P, Flaherty KT, Fisher DE, Wargo JA. BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma. Clinical Cancer Research 19(5):1225-31, 2013. e-Pub 2013. PMID: 23307859.
- Mitra D, Luo X, Morgan A, Wang J, Hoang MP, Lo J, Guerrero CR, Lennerz JK, Mihm MC, Wargo JA, Robinson KC, Devi SP, Vanover JC, D'Orazio JA, McMahon M, Bosenberg MW, Haigis KM, Haber DA, Wang Y, Fisher DE. An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background. Nature 491(7424):449-453, 2012. e-Pub 2012. PMID: 23123854.
- Levine CG, Mitra D, Sharma A, Smith CL, Hegde RS. The efficiency of protein compartmentalization into the secretory pathway. Molecular Biology of the Cell 16(1):279-91, 2005. e-Pub 2005. PMID: 15496459.
- Kim SJ, Mitra D, Salerno JR, Hegde RS. Signal sequences control gating of the protein translocation channel in a substrate-specific manner. Developmental Cell 2(2):207-217, 2002. e-Pub 2002. PMID: 11832246.
Invited Articles
- Farooqi AS, Guadagnolo BA, Mitra D, Bishop AJ. Radiation Therapy for Retroperitoneal Sarcomas: A Strass-Ful Situation. Curr Oncol 30(1):598-609, 2023. e-Pub 2023. PMID: 36661696.
- Mitra D, Bishop A, Guadagnolo BA. Adjuvant nodal radiation therapy for melanoma in the era of immunotherapy. Int J Radiat Oncol Biol Phys 108(1):164-169, 2020. e-Pub 2020. PMID: 32544573.
- Farooqi A, Mitra D, Guadagnolo BA, Bishop AJ. The Evolving Role of Radiation Therapy in Patients with Metastatic Soft Tissue Sarcoma. Curr Oncol Rep 22(8):79, 2020. e-Pub 2020. PMID: 32602007.
- Mito JK, Mitra D, Doyle LA. Radiation-Associated Sarcomas: An Update on Clinical, Histologic, and Molecular Features. Surg Pathol Clin 12(1):139-48, 2019. e-Pub 2019. PMID: 30709440.
- Mitra D, Klopp AH, Viswanathan AN. Pros and cons of vaginal brachytherapy after external beam radiation therapy in endometrial cancer. Gynecol Oncol 140(1):167-75, 2016. e-Pub 2016. PMID: 26432041.
- Mitra D, Fisher DE. Transcriptional regulation in melanoma. Hematol Oncol Clin North Am 23(3):447-65, viii, 2009. e-Pub 2009. PMID: 19464596.
Other Articles
- Sharafi CS, Guadagnolo BA, Nelson KC, Mitra D Adjuvant Radiation Therapy in Desmoplastic Melanoma: A Scoping Review. Cancers (Basel) 16(22), 2024. PMID: 39594829.
Editorials
- Mitra D, Robinson KC, Fisher DE. Melanoma and viagra: an unexpected connection. Pigment Cell & Melanoma Research 24(1):16-18, 2011. PMID: 21290790.
Abstracts
- Arifin AJ, Jerez O, Keatts S, Salem AFM, Farooqi A, Bishop AJ, Yoder AK, Goepfert RP, Weiser R, Amaria R, McQuade J, Ross MI, Guadagnolo BA, Mitra D. Adjuvant Primary Site Radiation Therapy for Melanoma in the Immunotherapy Era. Int J Radiat Oncol Biol Phys 120(2):S179-S180, 2024. e-Pub 2024.
- Dudzinski SO, Farooqi A, Roy S, Bishop AJ, Swanson D, Nagarajan P, Amaria R, McQuade J, Weiser R, Fisher S, Ross MI, Guadagnolo BA, Mitra D. Evaluation of Genomic and Pathologic Features Associated with Outcomes among Patients with Sentinel Lymph Node-Positive Melanoma in the Contemporary Era. Int J Radiat Oncol Biol Phys 120(2):S180, 2024. e-Pub 2024.
- Keatts S, Swanson A, Farooqi A, Bishop AJ, Amaria J, McQuade J, Glitza I, Diab A, Weiser R, Fisher S, Ross MI, Guadagnolo BA, Mitra D. Hypofractionated Radiation Therapy for Unresectable or Bulky Metastatic Melanoma. Int J Radiat Oncol Biol Phys 120(2):S180-S181, 2024. e-Pub 2024.
- Salem AFM, Chen M, Williams MD, Swanson D, McQuade J, Amaria R, Farooqi A, Bishop AJ, Hanna EY, Guadagnolo BA, Su SY, Mitra D. Sinonasal Melanoma Outcomes After Neoadjuvant Immunotherapy. Int J Radiat Oncol Biol Phys 120(2):e483-e484, 2024. e-Pub 2024.
- Arifin A, Bishop AJ, Mitra D, Araujo D, Haddad Nassif EF, Ratan R, Livingston JA, Lewis V, Lin P, Moon B, Keung E, Roland CL, Scally C, Guadagnolo BA, Farooqi A. Outcomes Following Combined Modality Treatment to the Primary Site in Patients with Metastatic Soft Tissue Sarcoma. Int J Radiat Oncol Biol Phys 120(2):e426-e427, 2024. e-Pub 2024.
- Onuma A, Malik N, Cope B, Aung P, Morey R, Ingram D, Arunkumar V, Chiang Y, Mitra D, Witt R, Keung E. Assessing the 10% rule in Sentinel Lymph Nodes Biopsy in Merkel Cell Cancer. Ann Surg Oncol 31(Suppl 1):1-294, 2024. e-Pub 2024.
- Mitra D, Gonzalez C, Swanson D, Bishop AJ, Farooqi A, Garden AS, Morrison WH, Goepfert RP, Esmaeli B, Ross MI, Wong MK, Ivan D, Guadagnolo BA. Adjuvant radiation therapy improves local control in the treatment of adnexal carcinoma. International Journal of Radiation Oncology, Biology, Physics 117(2):e325-e326, 2023. e-Pub 2023.
- Yoder AK, Farooqi A, Mitra D, Livingston JA, Araujo DM, Sturgis EM, Goepfert R, Bishop AJ, Guadagnolo BA. Outcomes for Patients with Head and Neck Sarcoma Treated Curatively with Radiation Therapy and Surgery 117(2):S149-S150, 2023. e-Pub 2023.
- Yoder AK, Netherton T, Wang XA, Lim TY, Wang H, Luo D, Wang C, Thrower SL, Farooqi A, Mitra D, Bishop AJ, Guadagnolo BA. Evaluating the Utility of Traditional Bowel Dose Constraints When Treating Abdominal and Pelvic Sarcomas with Preoperative Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics 117(2):E353-E354, 2023. e-Pub 2023.
- Witt RG, Cope B, Seervai R, Chiang YJ, Fisher SB, Lucci A, Gershenwald JE, Wargo JA, Ross MI, Wong MK, Mitra D, Keung EZ. Neoadjuvant Systemic Therapy for Merkel Cell Carcinoma: A Tertiary Referral Center Experience 29(SUPPL 2):353-353, 2022. e-Pub 2022.
- Mitra D, Ologun G, Bishop AJ, Goepfert RP, Keung E, Amaria R, Wargo J, Guadagnolo BA. Nodal Recurrence Rates for Melanoma Patients With ≥1 mm Sentinel Lymph Node Involvement in the Era of Adjuvant Immunotherapy. International Journal of Radiation Oncology 108(3):E1, 2020. e-Pub 2020.
- Mitra D, Horick N, Brackett DG, Mouw K, Hornick JL, Hong TS, Ryan DP, Parikh AR, Clark JW, Deshpande V, Wo JY. The immune milieu of anal squamous cell carcinoma: IDO expression is correlated with poor outcome. Journal of Clinical Oncology 102(3), 2018. e-Pub 2018.
- Mitra D, Agarwal V, Chen YH, Baldini EH, Barbie DA, Chen AB, Glass B, Beck A, Herman G, Kozono DE, Schoenfeld JD, Mak RH. The prognostic significance of PDL1 expression in locally advanced non-small-cell lung cancer treated with definitive intent. Journal of Clinical Oncology, 2018. e-Pub 2018.
- Mitra D, Mito J, Barysauskas CM, Raut CP, Doyle L, Baldini EH. Outcomes for Localized Radiation-Associated Sarcoma (RAS), Excluding Breast Angiosarcoma. International Journal of Radiation Oncology 99(2):755-6, 2017. e-Pub 2017.
- Mitra D, Hong TS, Horick N, Rose B, Drapek LN, Blaszkowsky LS, Allen JN, Kwak EL, Murphy JE, Clark JW, Ryan DP, Cusack JC, Bordeianou LG, Berger DL, Wo JY. Long term outcomes and toxicity of anal cancer patients treated per RTOG 0529. Adv Radiat Oncol 2(2):110-117, 2017. e-Pub 2017.
- Mitra D, Nout R, Creutzberg C, Lee L, Cimbak N, Viswanathan A. Does vaginal brachytherapy (VB) boost after external beam radiation therapy (EBRT) increase rectal bleeding? Comparing results of combined EBRT+VB to PORTEC-2 data for EBRT alone and VB alone. International Journal of Radiation Oncology 90(1), 2014. e-Pub 2014.
- D Mitra D, NC Cimbak NC, LJ Lee LJ, Viswanathan AA. Lymphedema: Is It Associated With Lymph-Node Involvement in Endometrial Cancer?. International Journal of Radiation Oncology 90(1):716-7, 2014. e-Pub 2014.
- Mitra D, Cimbak N, Damato AL, Lee L, Viswanathan A. Vaginal cuff brachytherapy after external beam radiation is not associated with a dose-related increase in late toxicities. Brachytherapy 13:77, 2014. e-Pub 2014.
- Mitra D, Shih HA, Oh KS, Brastianos PK, Wo JY, Curry WT, Clark JW, Parikh AR, Corcoran R, Ryan DP, Lennerz JK, Hong TS. Her2 positivity in brain metastases from gastrointestinal primary malignancies. Journal of Clinical Oncology 14(2), 2014. e-Pub 2014.
- Mitra D, Luo X, Morgan A, Wargo J, Fisher DE. Why redheads are at increased risk of melanoma: A novel BRAF mutant mouse model. American Association for Cancer Research 71(18), 2011. e-Pub 2011.
- Arifin AJ, Bishop AJ, Mitra D, Dejka A, Haddad EN, Ratan R, Livingston AJ, Lewis V, Lin P, Moon B, Keung E, Roland C, Scally C, Mericli AF, Guadagnolo BA, Farooqi A. Addressing the Primary Site in Patients with Metastatic Soft Tissue Sarcoma: Is There a Role for a Combined Modality Treatment?. CTOS 2024.
- Torres MB, Leung CH, Keung E, Feng C, Beird H, Zarzour A, Scally C, Hunt K, Conley A, Bishop AJ, Guadagnolo BA, Farooqi A, Mitra D, Araujo D, Livingston A, Ratan R, Shreyaskumar P, Ravi V, Lazar A, Roland CL, Somaiah N, Nassif EF. Dedifferentiated Liposarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Experience. CTOS 2023.
- Bishop AJ, Mitra D, Farooqi A, Hempel C, Bagchi C, Willis T, Pearlnath C, Wang WL, Ratan R, Somaiah N, Benjamin R, Torres KE, Hunt K, Scally C, Satcher RL, Bird J, Lin P, Moon B, Lewis V, Roland C, Guadagnolo BA. Long-term Disease Outcomes, Late Toxicity, and Function Following Hyprofractionated Preoperative Radiation Therapy for Patients with Soft Tissue Sarcomas: A HYPORT-STS Update. CTOS 2023.
- Gringrich AA, Beird H, Chu R, Traweek R, Cope B, Keung EZ, Scally CP, Hunt KK, Torres KE, Roland CL, Rare Tumor Initiative Team, Patient Mosaic Team, Futreal A, Bishop AJ, Guadagnolo BA, Mitra D, Farooqi A, Araujo D, Zarzour MA, Livingston JA, Conley A, Shreyaskumar P, Ravi V, Somaiah N, Lazar AJ, Ratan R, Nassif EF. Leiomyosarcoma Intratumoral Macrophage Infiltrates are Associated with Distinct Clinical and Genomic Presentations. CTOS 2023.
- Lillimoe H, Hunt K, Subramaniam A, Keung E, Roland C, Torres K, Lyu H, Scally C, Mitra D, Farooqi A, Bishop AJ, Guadagnolo BA, Ravi V. Primary Breast Angiosarcoma: Clinical and Pathological Features and Impact on Outcomes. CTOS 2023.
- Yoder A, Netherton T, Wang X, Lim TY, Wang H, Luo D, Wang C, Thrower S, Nguyen C, Mitra D, Bishop AJ, Farooqi A, Guadagnolo BA. The Impact of Tumor Location and Radiation Dose to Bowel on the Risk of Developing Gastrointestinal Toxicities when Treating Abdominopelvic Soft Tissue Sarcomas with Preoperative Radiation Therapy. CTOS 2023.
- Weiser R, McQuade J, Fisher S, Farooqi A, Amaria R, Guadagnolo BA, Bishop AJ, Patel SP, Diab A, Glitza IC, Bednarski BK, Ross MI, Mitra D. Combination of Radiotherapy and Immunotherapy or Patients Presenting with Locoregionally Advanced Anorectal Mucosal Melanoma. 2024 Society of Melanoma Research Congress.
Book Chapters
- Yoder AK, Mitra D, Bishop AJ, Guadagnolo BA. Merkel Cell Carcinoma. In: Pocket Radiation Oncology. 2nd.
- Yoder AK, Mitra D, Guadagnolo BA. Non-Melanoma Skin Cancer. In: Pocket Radiation Oncology. 2nd.
- Yoder AK, Mitra D, Guadagnolo BA. Melanoma. In: Pocket Radiation Oncology. 2nd.
Letters to the Editor
- Mitra D, Guadagnolo BA. Nodal Radiotherapy for Anorectal Melanoma: Finding the Appropriate Time and Place. Int J Radiat Oncol Biol Phys 120: 929-930, 2024.
Selected Presentations & Talks
Local Presentations
- 2025. PPPO Chart Rounds. Invited. Houston, Texas, US.
- 2024. Mel Sarc. Invited. Therapy Education Series. Houston, Texas, US.
- 2024. A radiation oncologist's foray into evaluation the role of the radiotherapy in the contemporary therapeutic era. Invited. Melanoma Research Seminar. Houston, Texas, US.
- 2024. The Role of Radiation Therapy in the Contemporary Management of Head and Neck Melanoma. Invited. Head and Neck - Plastic Reconstructive Surgery Melanoma Conference. Virtual, US.
- 2023. High Grade Sarcoma. Invited. High Grade Sarcoma. Houston, TX, US.
- 2023. Mechanisms and Rationale of Systemic Treatments for Cancer. Invited. Mechanisms and Rationale of Systemic Treatments for Cancer. Houston, TX, US.
- 2022. Identification of IO-TOX Features Through Utilization of Circulome Analysis. Conference. Identification of IO-TOX Features Through Utilization of Circulome Analysis. Houston, TX, US.
- 2022. Localized and Regional Melanoma Case Discussion. Conference. Localized and Regional Melanoma Case Discussion. Houston, TX, US.
- 2021. Proton Therapy for Abdominopelvic Sarcomas. Conference. Proton Therapy for Abdominopelvic Sarcomas. Houston, TX, US.
- 2020. Stage IV Disease. Conference. Stage IV Disease. Houston, TX, US.
- 2020. Complex Cases of Multidisciplinary Sarcoma Management. Conference. Complex Cases of Multidisciplinary Sarcoma Management. Houston, TX, US.
- 2020. Melanoma Socratic. Conference. Melanoma Socratic. Houston, TX, US.
- 2019. Complex Cases of Multidisciplinary Melanoma Management. Conference. Complex Cases of Multidisciplinary Melanoma Management. Houston, TX, US.
Regional Presentations
- 2021. The Evolving Role of Radiotherapy in Melanoma Management. Invited. Cancer Network Melanoma Retreat. Virtual, TX, US.
National Presentations
- 2025. Updates in Management for Melanoma. Invited. NASBS 34th Annual Meeting. New Orleans, LA, US.
- 2024. Sarcoma 2- Advancing Treatment Frontiers in Cutaneous Malignancies and Sarcoma. Invited. ASTRO 66th Annual Meeting. Washington DC, US.
- 2024. Contemporary FLASH-RT to its Clinical Translation- A Pathway to Bring Electron FLASH to Clinical Standard of Care. Invited. ASTRO 66TH Annual Meeting. Washington DC, US.
- 2024. New Technology Panel - Flash RT Updates. Invited. ASTRO 66th Annual Meeting. Washington DC, US.
- 2024. Sinonasal melanoma patterns of care and outcomes in the contemporary therapeutic era: a high-volume single institution experience. Invited. Multidisciplinary Head and Neck Cancers Symposium 2024. Phoenix, AZ, US.
- 2023. Adjuvant Radiation Therapy Improves Local Control in the Treatment of Adnexal Carcinoma. Invited. ASTRO 65th Annual Meeting. San Diego, CA, US.
- 2022. Gynecologic Melanoma: A 25-Year Institutional Experience. Invited. ASTRO 2022 Annual Meeting. San Antonio, TX, US.
- 2022. Prospective Single-Arm Trial of Preoperative 42.75 Gy in 15 Fractions for Soft Tissue Sarcoma of Extremity/Trunk. Invited. ASTRO 2022 Annual Meeting. San Antonio, TX, US.
- 2022. Stereotactic Ablative Radiation Therapy for Sarcoma Lung Metastases: Indications for Treatment and Patterns of Failure. Invited. ASTRO 2022 Annual Meeting. San Antonio, TX, US.
- 2022. Anatomic Variability in Patterns of Care for Locoregional Merkel Cell Carcinoma (MCC) Management at a Large Referral Center. Invited. \ASTRO 2022 Annual Meeting. San Antonio, TX, US.
- 2022. Outcomes after Definitive Treatment for Cutaneous Angiosarcomas of the Face and Scalp: Re-Evaluating the Role of Combined Modality Treatment. Invited. ASTRO 2022 Annual Meeting. San Antonio, TX, US.
- 2022. The Role of Radiation in Melanoma in the Era of Immunotherapy and Targeted Therapies. Invited. ASTRO 2022 Annual Meeting. San Antonio, TX, US.
- 2021. Updates in Locoregional Skin Cancer Management. Invited. 63rd ASTRO Annual Meeting. Virtual, US.
- 2021. Patterns of Recurrence in Patients with Sentinel Lymph Node (SLN) Positive Melanoma in the Post-Multicenter Selective Lymphadenectomy Trial II (MSLT-II) Era. Invited. Patterns of Recurrence in Patients with Sentinel Lymph Node (SLN) Positive Melanoma in the Post-Multicenter Selective Lymphadenectomy Trial II (MSLT-II) Era, US.
- 2014. Vaginal cuff brachytherapy after external beam radiation is not associated with a dose-related increase in late toxicities. Invited. American Brachytherapy Society Annual Meeting. San Diego, CA, US.
- 2011. Why redheads are at increased risk of melanoma: A novel BRAF mutant mouse model. Invited. Society for Melanoma Research Annual Meeting. Tampa, FL, US.
- 2011. Why redheads are at increased risk of melanoma: A novel BRAF mutant mouse model. Invited. AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. San Francisco, CA, US.
International Presentations
- 2023. Hypofractionated Flash Radiation Treatment Reduces Skin and Soft Tissue Toxicity in a Murine Model. Invited. Flash Radiotherapy & Particle Therapy (FRPT) Annual Meeting. Toronto, CA.
Formal Peers
- 2024. Pre-Operative Radiotherapy and Immunotherapy for Sinonasal Melanoma. Virtual, US.
- 2023. MD Anderson Network Retreat’s Multidisciplinary Care Discussion Panel. Visiting. MD Anderson Network Retreat’s Multidisciplinary Care Discussion Panel. Virtual, US.
- 2023. Exploring Controversies in Management of Cutaneous Malignant Melanoma of the Head and Neck. Visiting. Exploring Controversies in Management of Cutaneous Malignant Melanoma of the Head and Neck. Virtual, US.
- 2023. Introduction to Clinical Oncology/ Radiation Oncology. Visiting. Introduction to Clinical Oncology/ Radiation Oncology. Houston, TX, US.
- 2023. The Evolving Role of Radiotherapy in Melanoma Management. Visiting. The Evolving Role of Radiotherapy in Melanoma Management. Jacksonville, FL, US.
- 2022. Melanoma/Cutaneous Multidisciplinary Presentation. Invited. Melanoma/Cutaneous Multidisciplinary Presentation. Gilbert, AZ, US.
- 2021. Melanoma Lecture for Clinical Oncology Residents from the Cancer Diseases Hospital in Lusaka, Zambia. Visiting. Melanoma Lecture for Clinical Oncology Residents from the Cancer Diseases Hospital in Lusaka, Zambia, US.
- 2021. Lunch and Learn Faculty Seminar. Invited. Lunch and Learn Faculty Seminar. Houston, TX, US.
- 2020. Non-Melanoma Skin Cancer. Visiting. Non-Melanoma Skin Cancer. Houston, TX, US.
- 2019. Malignant Melanoma. Visiting. Malignant Melanoma. Houston, TX, US.
Grant & Contract Support
| Date: | 2024 - 2026 |
| Title: | Neoadjuvant immunotherapy and radiotherapy for mucosal melanoma |
| Funding Source: | Melanoma Research Foundation |
| Role: | PI |
| ID: | FP00021976 |
| Date: | 2024 - 2026 |
| Title: | FLASH-RT: A novel approach for cutaneous melanoma |
| Funding Source: | Sabin Family Foundation |
| Role: | PI |
| Date: | 2023 - 2025 |
| Title: | Prediction of Radiation Therapy Associated Toxicity to Correct a Race-Based Disparity |
| Funding Source: | Radiological Society of North America (RSNA) |
| Role: | PI |
| ID: | RSCH2215 |
| Date: | 2023 - 2026 |
| Title: | Study on Ultra- high dose rate radiotherapy for any cutaneous or subcutaneous tumor |
| Funding Source: | Radiation Oncology Strategic Initiatives (ROSI) |
| Role: | PI |
| Date: | 2022 - 2024 |
| Title: | Comparing superficial tissue toxicity with FLASH-RT vs. CONV-RT |
| Funding Source: | MD Anderson Department of Radiation Oncology |
| Role: | PI |
| Date: | 2021 - 2023 |
| Title: | Post- operative radiation therapy for high risk sentinel lymph node positive melanoma patients planned for immunotherapy |
| Funding Source: | Radiation Oncology Strategic Initiatives (ROSI) |
| Role: | PI |
| Date: | 2021 - 2024 |
| Title: | Institutional Career Development Core (CTSA-KL2) |
| Funding Source: | National Center for Advancing Translational Sciences (NCATS) |
| Role: | PI |
| ID: | KL2TR003168 |
| Date: | 2021 - 2022 |
| Title: | Investigate the effect of HANRT for high risk SLN+ melanoma patients receiving adjuvant anti-PD1 in the absence of CLND. In addition, identify predictive biomarkers of treatment-associated toxicity and disease recurrence for SLN+ melanoma patients receiving adjuvant anti-PD1 with and without HANRT |
| Funding Source: | Radiation Oncology Strategic Initiatives (ROSI) |
| Role: | PI |
| Date: | 2020 - 2021 |
| Title: | MD Anderson Melanoma SPORE |
| Funding Source: | National Cancer Institute (NCI) |
| Role: | PI |
| ID: | P50CA221703 |
| Date: | 2018 - 2019 |
| Title: | Radiation therapy in immune checkpoint inhibitor resistant head and neck cancer |
| Funding Source: | American Society of Clinical Oncology (ASCO) |
| Role: | PI |
| Date: | 2017 - 2018 |
| Title: | Investigating the immunomodulatory effects of radiation with and without immune checkpoint inhibition in squamous cell carcinoma of the head and neck |
| Funding Source: | American Society for Therapeutic Radiology and Oncology (ASTRO) |
| Role: | PI |
| Date: | 2012 - 2013 |
| Title: | The role of ultraviolet radiation and skin pigmentation in melanoma development |
| Funding Source: | National Institute of Environmental Health Sciences |
| Role: | PI |
Patient Reviews
CV information above last modified April 29, 2025